On 9 January 2015, with Hong Yuhao, Yao Bohua and Hong Kong office as legal counsel, China Regenerative Medicine International Limited, a public company incorporated in Cayman Island and listed on Hong Kong Growth Enterprise Market, announced its purchasing of share of Frame Sharp Limited through contract arrangement.